Search results
How the Chicago Sky's guard rotation was tested in a 77-68 loss to Seattle
WFLD via Yahoo Sports· 6 days agoIt was something the team will work on in practice. But, a positive is that Weatherspoon found...
Covid will still be here this summer. Will anyone care?
Washington Post via Yahoo News· 3 days agoCorrection: A previous version of this article said the CDC revised its covid quarantine protocols...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 4 days agoWhen will it be ready? Prof Harrington said that the drug is “extremely promising”. However, AOH1996...
8 Lifestyle Factors May Slow Aging, Reduce Risk of Death
Healthline via AOL· 6 days agoOn the other hand, in people with greater genetic risk, this figure was nearly doubled. Why...
Millions more trees isn’t the climate fix New Zealand thought
Hartford Courant· 7 days agoOf all the solutions for a warming world, “plant more trees” seems pretty obvious. “Pine production...
Trump vs. Biden: Conservatives can choose not to choose
USA Today· 4 days agoIn the spring of 2012, I found myself alone for several minutes in a network green room with Ben...
‘I can’t explain why’: Does this dog dewormer cure cancer? These Facebook groups say yes
The Daily Dot· 4 days agoThree months later, the cancer had grown. From a cattle farm in Louisiana where she’s helping a...
Hong Kong proves ideal base for Rainbow Genomics to expand accredited medical services
South China Morning Post· 4 days agoHong Kong Trade Development Council figures show the total of new businesses in the city grew by 7...
Lab-grown meat isn't on store shelves yet, but some states have already banned it
Napa Valley Register· 3 days agoLab-grown meat is not available in any U.S. grocery stores or restaurants. Florida and Arizona...
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024...
Morningstar· 4 days agoTG Therapeutics, Inc. (NASDAQ: TGTX), today announced presentations highlighting study designs for post-marketing studies being undertaken for BRIUMVI® (ublituximab-xiiy) in patients with relapsing ...